Le Lézard
Classified in: Health, Covid-19 virus
Subject: MRR

PD-1 And PD-L1 Inhibitors Market to Record a CAGR of 19.31%, Increasing Prevalence of Cancer to Boost Market Growth - Technavio


NEW YORK, Sept. 23, 2022 /PRNewswire/ -- The "PD-1 And PD-L1 Inhibitors Market by Application (solid tumors and blood-related tumors) and Geography (North America, Europe, Asia, and Rest of World (ROW)) - Forecast and Analysis 2022-2026" report has been added to Technavio's offering. The potential growth difference for the PD-1 and PD-l1 inhibitors market size between 2021 and 2026 is USD 49.34 billion. To get the exact CAGR and the Y-O-Y growth rate, Request a FREE PDF Sample Report

Regional Analysis

North America will account for 51% of the market's growth during the forecast period. This growth is attributed to factors such as the increasing prevalence of various solid tumors and blood-related tumors in the region and the sales of approved therapeutics. However, market growth in this region will be slower than the growth of the market in other regions. The US and Canada are the key countries for the PD-1 and PD-L1 inhibitors market in North America.

Key Market Dynamics

Technavio has identified key trends, drivers, and challenges in the PD-1 and PD-L1 inhibitors market, which will help vendors improve their strategies to stay ahead of their competitors. View our FREE PDF Sample Report

Market Segmentation

By application, the blood-related tumors segment will be the largest contributor to market growth during the forecast period. The growth of this segment is attributed to factors such as the strong prevalence of leukemia and various types of lymphomas globally.

View our FREE PDF sample report for additional insights into the contribution of all the segments and regional opportunities in the report.

Some Companies Mentioned

Want your report customized? Speak to an analyst and personalize your report according to your needs

Related Reports

Point of Care Diagnostics Market by Product, End-user, and Geography - Forecast and Analysis 2022-2026: The point of care diagnostics market share is expected to increase by USD 13.09 billion from 2021 to 2026.

Pharmacogenomics Market by End-user and Geography - Forecast and Analysis 2022-2026: The pharmacogenomics market share is expected to increase by USD 2.50 billion from 2021 to 2026.

PD-1 And PD-L1 Inhibitors Market Scope

Report Coverage

Details

Page number

120

Base year

2021

Forecast period

2022-2026

Growth momentum & CAGR

Accelerate at a CAGR of 19.31%

Market growth 2022-2026

USD 49.34 billion

Market structure

Fragmented

YoY growth (%)

18.6

Regional analysis

North America, Europe, Asia, and Rest of World (ROW)

Performing market contribution

North America at 51%

Key consumer countries

US, Canada, Germany, UK, and France

Competitive landscape

Leading companies, competitive strategies, consumer engagement scope

Companies profiled

Akeso Inc., Alphamab Oncology, Amgen Inc., AstraZeneca Plc, BeiGene Ltd., Bristol Myers Squibb Co., Chia Tai Tianqing Pharmaceutical Group Co. Ltd., Eli Lilly and Co., F. Hoffmann La Roche Ltd., Gilead Sciences Inc., GlaxoSmithKline Plc, Innovent Biologics Inc., Jiangsu Hengrui Pharmaceuticals Co. Ltd., Merck and Co. Inc., Merck KGaA, Novartis AG, Pfizer Inc., Regeneron Pharmaceuticals Inc., Sanofi, and Shanghai Jhunsi Biosciences Ltd.

Market Dynamics

Parent market analysis, market growth inducers and obstacles, fast-growing and slow-growing segment analysis, COVID-19 impact and future consumer dynamics, and market condition analysis for the forecast period.

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Browse Health Care Market Reports

Key Topics Covered

1 Executive Summary

2 Market Landscape

3 Market Sizing

4 Five Forces Analysis

5 Market Segmentation by Application

6 Customer Landscape

7 Geographic Landscape

8 Drivers, Challenges, and Trends

9 Vendor Landscape

10 Vendor Analysis

11 Appendix

About Us

Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contact
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email:[email protected]
Website: www.technavio.com/

SOURCE Technavio


These press releases may also interest you

at 20:30
The Augmented Reality and Virtual Reality Market by Technology, Application, and Geography - Forecast and Analysis 2023-2027 report has been published by Technavio. Market growth is estimated to accelerate at a CAGR of 52.37% and register an...

at 17:00
Toubani Resources, Inc. ("Toubani Resources" or the "Company") is pleased to announce that the Company`s securities will commence trading today on the Australian Securities Exchange ("ASX") under the ASX code TRE. Highlights: Shares were...

at 11:45
GE Healthcare today announced the launch of SIGNA Experience, a platform of four synergistic technologies that help users through the diagnostic journey. This integrated collection works together to ensure the smoothest magnetic resonance imaging...

at 10:30
HeartVista, a pioneer and leader in automated MRI solutions, today announced that it has changed its name to Vista.ai as the company broadens its sights to simplify and enhance MRI exams for anatomies beyond the heart. A major academic medical center...

at 09:05
Ahead of its planned spinoff from GE the first week of January 2023, GE Healthcare reveals over 40 solutions that aim to improve patient outcomes and increase healthcare efficiency at the Radiological Society of North America's (RSNA) 2022 Annual...

at 07:30
The Rugged Servers Market by End-user, Type, and Geography - Forecast and Analysis 2023-2027 report has been published by Technavio. Market growth is estimated to accelerate at a CAGR of 5.51% and register an incremental growth of USD 751.25 million...



News published on 23 september 2022 at 21:30 and distributed by: